Literature DB >> 9752623

Bioethics of the refusal of blood by Jehovah's Witnesses: Part 1. Should bioethical deliberation consider dissidents' views?

O Muramoto1.   

Abstract

Jehovah's Witnesses' (JWs) refusal of blood transfusions has recently gained support in the medical community because of the growing popularity of "no-blood" treatment. Many physicians, particularly so-called "sympathetic doctors", are establishing a close relationship with this religious organization. On the other hand, it is little known that this blood doctrine is being strongly criticized by reform-minded current and former JWs who have expressed conscientious dissent from the organization. Their arguments reveal religious practices that conflict with many physicians' moral standards. They also suggest that a certain segment of "regular" or orthodox JWs may have different attitudes towards the blood doctrine. The author considers these viewpoints and argues that there are ethical flaws in the blood doctrine, and that the medical community should reconsider its supportive position. The usual physician assumption that JWs are acting autonomously and uniformly in refusing blood is seriously questioned.

Keywords:  Internet; Professional Patient Relationship; Religious Approach

Mesh:

Year:  1998        PMID: 9752623      PMCID: PMC1377670          DOI: 10.1136/jme.24.4.223

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  5 in total

1.  The blood transfusion taboo of Jehovah's Witnesses: origin, development and function of a controversial doctrine.

Authors:  R Singelenberg
Journal:  Soc Sci Med       Date:  1990       Impact factor: 4.634

2.  Jehovah's Witnesses leading education drive as hospitals adjust to no blood requests.

Authors:  N Robb
Journal:  CMAJ       Date:  1996-02-15       Impact factor: 8.262

3.  Medical ethics in the treatment of Jehovah's Witnesses.

Authors:  O Muramoto
Journal:  Arch Intern Med       Date:  1998-05-25

Review 4.  Isolating fetal cells in maternal circulation for prenatal diagnosis.

Authors:  J L Simpson; S Elias
Journal:  Prenat Diagn       Date:  1994-12       Impact factor: 3.050

5.  Surgical red blood cell transfusion practice policies. Blood Management Practice Guidelines Conference.

Authors:  R K Spence
Journal:  Am J Surg       Date:  1995-12       Impact factor: 2.565

  5 in total
  14 in total

Review 1.  Recent developments in medical care of Jehovah's Witnesses.

Authors:  O Muramoto
Journal:  West J Med       Date:  1999-05

2.  Jehovah's Witnesses' refusal of blood: obedience to scripture and religious conscience.

Authors:  D T Ridley
Journal:  J Med Ethics       Date:  1999-12       Impact factor: 2.903

Review 3.  Bioethics of the refusal of blood by Jehovah's Witnesses: Part 3. A proposal for a don't-ask-don't-tell policy.

Authors:  O Muramoto
Journal:  J Med Ethics       Date:  1999-12       Impact factor: 2.903

4.  Bioethical aspects of the recent changes in the policy of refusal of blood by Jehovah's witnesses.

Authors:  O Muramoto
Journal:  BMJ       Date:  2001-01-06

5.  Medical confidentiality and the protection of Jehovah's Witnesses' autonomous refusal of blood.

Authors:  O Muramoto
Journal:  J Med Ethics       Date:  2000-10       Impact factor: 2.903

6.  Why some Jehovah's Witnesses accept blood and conscientiously reject official Watchtower Society blood policy.

Authors:  L Elder
Journal:  J Med Ethics       Date:  2000-10       Impact factor: 2.903

7.  Surgery and religiosity.

Authors:  J J Brown; T G Ijaduola
Journal:  J Natl Med Assoc       Date:  2001-03       Impact factor: 1.798

8.  A Jehovah's Witness adolescent with pancytopenia.

Authors:  Lauren Kitney; Ronik Kanani; Claire De Souza
Journal:  CMAJ       Date:  2012-05-14       Impact factor: 8.262

9.  Autonomy-Centered Healthcare.

Authors:  Maura Priest
Journal:  HEC Forum       Date:  2018-09

10.  Bioethics of the refusal of blood by Jehovah's Witnesses: Part 2. A novel approach based on rational non-interventional paternalism.

Authors:  O Muramoto
Journal:  J Med Ethics       Date:  1998-10       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.